Alpha/Beta T Cell and CD19+ B Cell Depletion

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 2
Enrollment
20 patients (estimated)
Sponsors
University of Florida Health Cancer Center
Collaborators
Ocala Royal Dames for Cancer Research
Tags
Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
1873
NCT Identifier
NCT05800210

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.